1. Home
  2. GNFT vs BLDE Comparison

GNFT vs BLDE Comparison

Compare GNFT & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • BLDE
  • Stock Information
  • Founded
  • GNFT 1999
  • BLDE 2014
  • Country
  • GNFT France
  • BLDE United States
  • Employees
  • GNFT N/A
  • BLDE N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • BLDE Aerospace
  • Sector
  • GNFT Health Care
  • BLDE Consumer Discretionary
  • Exchange
  • GNFT Nasdaq
  • BLDE Nasdaq
  • Market Cap
  • GNFT 249.0M
  • BLDE 276.7M
  • IPO Year
  • GNFT 2019
  • BLDE N/A
  • Fundamental
  • Price
  • GNFT $6.07
  • BLDE $3.45
  • Analyst Decision
  • GNFT Strong Buy
  • BLDE
  • Analyst Count
  • GNFT 1
  • BLDE 0
  • Target Price
  • GNFT $13.00
  • BLDE N/A
  • AVG Volume (30 Days)
  • GNFT 26.3K
  • BLDE 527.4K
  • Earning Date
  • GNFT 09-19-2024
  • BLDE 11-06-2024
  • Dividend Yield
  • GNFT N/A
  • BLDE N/A
  • EPS Growth
  • GNFT N/A
  • BLDE N/A
  • EPS
  • GNFT 0.47
  • BLDE N/A
  • Revenue
  • GNFT $86,225,222.00
  • BLDE $238,379,000.00
  • Revenue This Year
  • GNFT $155.44
  • BLDE $12.14
  • Revenue Next Year
  • GNFT N/A
  • BLDE $11.35
  • P/E Ratio
  • GNFT $12.34
  • BLDE N/A
  • Revenue Growth
  • GNFT 175.45
  • BLDE 25.39
  • 52 Week Low
  • GNFT $2.97
  • BLDE $2.06
  • 52 Week High
  • GNFT $6.08
  • BLDE $4.25
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 64.35
  • BLDE 61.63
  • Support Level
  • GNFT $5.41
  • BLDE $3.37
  • Resistance Level
  • GNFT $6.08
  • BLDE $3.58
  • Average True Range (ATR)
  • GNFT 0.30
  • BLDE 0.15
  • MACD
  • GNFT 0.03
  • BLDE 0.04
  • Stochastic Oscillator
  • GNFT 77.38
  • BLDE 87.35

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: